Ocular Therapeutix (OCUL) Treasury Shares (2014 - 2025)

Ocular Therapeutix has reported Treasury Shares for 5 years, with the latest figure at $4.4 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 28.61% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $4.4 million (up 28.61% YoY), and the FY2025 full-year result was $4.4 million, up 28.61% from the prior year.
• Treasury Shares for Q4 2025 stood at $4.4 million, up from $3.4 million in the prior quarter.
• The five-year high for Treasury Shares was $4.4 million in Q4 2025, with the low at $1.1 million in Q4 2022.
• Average Treasury Shares over 4 years is $2.6 million, with a median of $2.5 million recorded in 2023.
• Year-over-year, Treasury Shares jumped 108.29% in 2024 and climbed 28.61% in 2025.
• Tracing OCUL's Treasury Shares over 4 years: stood at $1.1 million in 2022, then jumped by 48.93% to $1.6 million in 2023, then jumped by 108.29% to $3.4 million in 2024, then climbed by 28.61% to $4.4 million in 2025.
• The last three Treasury Shares figures came in at $4.4 million (Q4 2025), $3.4 million (Q4 2024), and $1.6 million (Q4 2023), per Business Quant data.

Peer Comparison